BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 918118)

  • 21. Predicting response to tamoxifen in metastatic breast cancer.
    Connor JL; Foley JF; Lemon HM
    Nebr Med J; 1986 Dec; 71(12):422-6. PubMed ID: 3796760
    [No Abstract]   [Full Text] [Related]  

  • 22. [The estrogen receptor in breast carcinoma in male patients and the tamoxifen response].
    Gómez Cruz P; Rivadeneyra Hinojosa J; García-Alonso H; Rábago Velasco M
    Ginecol Obstet Mex; 1988 Nov; 56():310-4. PubMed ID: 2856451
    [No Abstract]   [Full Text] [Related]  

  • 23. The significance of estrogen receptors in tamoxifen and toremifene therapy.
    Valavaara R; Kangas L
    Ann Clin Res; 1988; 20(5):380-8. PubMed ID: 2975479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of advanced breast cancer with multiple organ metastases successfully treated by tamoxifen].
    Shiba E; Kobayashi T; Takeda T; Miya A; Kawano I; Takai S; Mori T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2255-8. PubMed ID: 1444494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
    Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
    Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA; Palmer DH; Moon S; Rea DW
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen.
    Kopp A; Jonat W; Schmahl M; Knabbe C
    Cancer Res; 1995 Oct; 55(20):4512-5. PubMed ID: 7553618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of tamoxifen in advanced male breast cancer.
    Patterson JS; Battersby LA; Bach BK
    Cancer Treat Rep; 1980; 64(6-7):801-4. PubMed ID: 7427964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM; Gershanovich MA
    Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients.
    Viladiu P; Bosch FX; Benito E; Alonso MC
    Cancer Treat Rep; 1977 Aug; 61(5):899-900. PubMed ID: 329983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of the estrogen antagonist tamoxifen in the treatment of advanced mastocarcinoma (author's transl)].
    Szepesi T; Kärcher KH
    Strahlentherapie; 1977 Dec; 153(12):832-6. PubMed ID: 341420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
    Ward HW
    Clin Oncol; 1977 Mar; 3(1):91-5. PubMed ID: 862280
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of tamoxifen therapy in patients with breast cancer.
    Firusian N; Ohl S; Becher R
    Recent Results Cancer Res; 1980; 71():142-5. PubMed ID: 7367725
    [No Abstract]   [Full Text] [Related]  

  • 38. Experience with 6-aminoglutethimide in the treatment of metastatic breast cancer.
    Koelmeyer TD; Stephens EJ; Wood HF
    Clin Oncol; 1978 Dec; 4(4):323-7. PubMed ID: 729221
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal therapy with tamoxifen in male breast cancer.
    Hortobagyi GN; DiStefano A; Legha SS; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1979 Apr; 63(4):539-41. PubMed ID: 221118
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].
    Mouridsen HT; Palshof T; Patterson J; Battersby L
    Ugeskr Laeger; 1979 Jul; 141(31):2108-13. PubMed ID: 483408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.